2Y6T image
Deposition Date 2011-01-26
Release Date 2011-04-20
Last Version Date 2024-11-20
Entry Detail
PDB ID:
2Y6T
Title:
Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.74 Å
R-Value Free:
0.31
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CHYMOTRYPSINOGEN A
Chain IDs:A, B, C, D
Chain Length:245
Number of Molecules:4
Biological Source:BOS TAURUS
Polymer Type:polypeptide(L)
Molecule:ECOTIN
Gene (Uniprot):eco
Chain IDs:E, F, G, H
Chain Length:148
Number of Molecules:4
Biological Source:YERSINIA PSEUDOTUBERCULOSIS
Ligand Molecules
Primary Citation
Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia Pestis.
J.Biol.Chem. 286 24015 ? (2011)
PMID: 21531711 DOI: 10.1074/JBC.M111.225730

Abstact

Resistance to antibiotics is a problem not only in terms of healthcare but also biodefense. Engineering of resistance into a human pathogen could create an untreatable biothreat pathogen. One such pathogen is Yersinia pestis, the causative agent of plague. Previously, we have used a bioinformatic approach to identify proteins that may be suitable targets for antimicrobial therapy and in particular for the treatment of plague. The serine protease inhibitor ecotin was identified as one such target. We have carried out mutational analyses in the closely related Yersinia pseudotuberculosis, validating that the ecotin gene is a virulence-associated gene in this bacterium. Y. pestis ecotin inhibits chymotrypsin. Here, we present the structure of ecotin in complex with chymotrypsin to 2.74 Å resolution. The structure features a biologically relevant tetramer whereby an ecotin dimer binds to two chymotrypsin molecules, similar to what was observed in related serine protease inhibitor structures. However, the vast majority of the interactions in the present structure are distinctive, indicating that the broad specificity of the inhibitor for these proteases is based largely on its capacity to recognize features unique to each of them. These findings will have implications for the development of small ecotin inhibitors for therapeutic use.

Legend

Protein

Chemical

Disease